4.6 Article

Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations

Journal

PROTEIN SCIENCE
Volume 20, Issue 7, Pages 1114-1118

Publisher

WILEY-BLACKWELL
DOI: 10.1002/pro.661

Keywords

acetylcholinesterase; X-ray crystallography; sub-domain; molecular dynamics simulations; substrate traffic; backdoor

Funding

  1. CEA
  2. CNRS
  3. UJF
  4. Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0192-04]
  5. DGA [DGA-REI 2009-34-0023]
  6. National Natural Science Foundation of China [31050110434]
  7. State Key Program of Basic Research of China [2009CB918501]
  8. Computer Network Information Center (CNIC) of the Chinese Academy of Sciences (CAS)
  9. Shanghai Supercomputing Center (SCC) of the CAS
  10. European Commission [031220, ISSG-CT-2007-037198]
  11. Kimmelman Center for Biomolecular Structure and Assembly
  12. Benoziyo Center for Neurosciences
  13. Nalvyco Foundation
  14. Bruce Rosen Foundation
  15. Jean and Julia Goldwurm Memorial Foundation
  16. Chinese Academy of Science
  17. Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0192] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

The transient opening of a backdoor in the active-site wall of acetylcholinesterase, one of nature's most rapid enzymes, has been suggested to contribute to the efficient traffic of substrates and products. A crystal structure of Torpedo californica acetylcholinesterase in complex with the peripheral-site inhibitor aflatoxin is now presented, in which a tyrosine at the bottom of the active-site gorge rotates to create a 3.4-angstrom wide exit channel. Molecular dynamics simulations show that the opening can be further enlarged by movement of Trp84. The crystallographic and molecular dynamics simulation data thus point to the interface between Tyr442 and Trp84 as the key element of a backdoor, whose opening permits rapid clearance of catalysis products from the active site. Furthermore, the crystal structure presented provides a novel template for rational design of inhibitors and reactivators, including anti-Alzheimer drugs and antidotes against organophosphate poisoning.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available